Instem Share Price. INS - Stock Quote, Charts, Trade History, Share Chat, Financials. Instem Plc

Gold vs US Dollar

Home
Investing
Stocks
UK
LSE
Instem Plc (INS)
Instem Plc (INS) Share Price

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Instem Plc	LSE:INS	London	Ordinary Share	GB00B3TQCK30	ORD 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-10.00	-1.56%	630.00	44,908	09:31:56

Bid Price		Offer Price	High Price	Low Price	Open Price
620.00		640.00	665.00	630.00	640.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Computer Related Svcs, Nec	46.82	1.68	7.60	91.43	143.42

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
16:18:44	O	12,500	625.00	GBX

Related Shares
Sage (SGE), Ig (IGG), Osirium Technologies (OSI), Actual Experience (ACT)

Instem (INS) Latest News

Instem News

Date	Time	Source	Headline
18/5/2023	09:14	UKREG	Instem plc Holding(s) in Company
15/5/2023	12:30	ALNC	Instem acquires new platform following annual profit growth
15/5/2023	07:01	UKREG	Instem plc Final Results & Investor Presentation
15/5/2023	07:00	UKREG	Instem plc Transfer of ToxHub Platform and launch of Centrus(R)
15/5/2023	06:40	ALNC	GET READY: CentralNic, Cerillion, Currys, Diploma, Instem at 0700 BST
11/5/2023	15:26	UKREG	Instem plc Holding(s) in Company
11/5/2023	14:46	ALNC	Instem renews long-term contract with US National Toxicology Program
11/5/2023	07:00	RNSNON	Instem plc US Government Contract Award
04/5/2023	17:07	UKREG	Instem plc Holding(s) in Company
03/5/2023	07:00	UKREG	Instem plc Notice of Results and Investor Presentation

More Instem News

Instem Investors Instem Takeover Rumours

Instem (INS) Discussions and Chat

Instem Forums and Chat

Date	Time	Title	Posts
18/5/2023	12:54	Instem Life	236
26/11/2019	16:54	chevy retail 250	1
02/1/2012	22:19	INSULTS...what is the best one ?	11
05/1/2010	16:26	Newbie to BB ! any viewpoint	30
13/4/2008	14:52	INTERNATIONAL NUCLEAR SOLUTIONS double your money	132

Add a New Thread

Instem (INS) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2023-05-31 17:18:45	625.00	12,500	78,125.00	O
2023-05-31 17:18:40	625.00	12,500	78,125.00	O
2023-05-31 13:17:57	630.00	950	5,985.00	O
2023-05-31 12:22:18	630.00	1,585	9,985.50	O
2023-05-31 12:00:22	630.00	3,966	24,985.80	O

View all Instem trades in real-time

Instem (INS) Top Chat Posts

Top Posts
Posted at 15/5/2023 22:28 by elrico Adjusted EBITDA loss and net cash outflow resulting from its buy-and-build acquisitions have had an impact on 2022. Investors should focus on what INS has built with accretive acquisitions. hTTps://twitter.com/LEMMINGINVESTOR/status/1658221438396923906 Read Full Thread Follow Reply
Posted at 28/9/2022 08:20 by tradertrev ...as was the InvestorMeetCompany presentation yesterday afternoon. However, in the current market mood it's a case of "believe it when you see it" so I suspect we have to wait a couple of months before we see significant share price recovery. Happy to hold for that. Read Full Thread Follow Reply
Posted at 21/2/2022 17:22 by km18 ...from last year... Company overview: Instem plc is a major supplier of technology and services for the healthcare sector. The company is working with 600 clients providing them with shorter R&D cycles, better management controls, effective resource utilization and increased regulatory compliance. INS prides itself with 98% client retention rate and they strive to be not simply a provider of services but a strategic partner to their clients. The limited number of acquisitions mean the balance sheet is light on intangibles and growth is based on a blended approach. fundamentally the company is strong. Revenue is growing at 11.6% CAGR and “normalised” EPS on Stockopedia is at CAGR of 28.9%. ROCE for last year was at 8.02% and net gearing is negative. Cash generation is strong driven by continuous increase in CFO. Any issues? Valuation would be the biggest, with rolling P/e in the 30s, which is about the average for the sector. P/S is on the higher end at 7.08 and same could be said also for the EV/EBITDA being in the low 30s. The interim results are showing good performance. Total revenue is up by 41% to £19.8m, of which recurring is £9.9m. PBT is actually below the H1 2020 at £1.2m, leading to lower EPS as well, due to amortisation of intangibles from acquisitions. The company is enjoying continuous transition to the SaaS model which is increasing the visibility of earnings.... ...from WealthOracleAM https://wealthoracle.co.uk/detailed-result-full/INS/171 Read Full Thread Follow Reply
Posted at 03/9/2021 20:44 by mw8156 good deal of consolidation going on in drug development software, INS having acquired the smaller Swiss competitor and Certara having acquired Pinnacle 21 in the USA. Read Full Thread Follow Reply
Posted at 24/5/2021 17:15 by pugugly https://www.dailymail.co.uk/money/investing/article-9613361/SMALL-CAP-SHARE-IDEAS-Instem.html Read Full Thread Follow Reply
Posted at 30/3/2021 15:56 by jombaston I don't think there are any in the UK, not listed anyway. Phil Reason mentioned a company called Cetara which is NASDAQ listed. They have a $3.9bn mkt cap which is 14x their projected 2021 sales. Instem mkt cap of £133m is 2.7x 2021E revenue. EV/EBITDA Cetara is 38.2x whereas INS is 14.4x. Their products are more complements than substitutes even though they operate in the same field and obviously you would expect NASDAQ companies to be rated more highly because, er, well, they just are! Read Full Thread Follow Reply
Posted at 15/3/2021 22:41 by mw8156 buy price 577 sell price 580 this morning albeit for only 500 shares...market maker short of stock? Read Full Thread Follow Reply
Posted at 15/11/2020 12:17 by p1nkfish Back near placing price too. Read Full Thread Follow Reply
Posted at 26/6/2020 22:22 by p1nkfish Interesting statement. "The 'working from home' impact of COVID-19 has increased the number of conversations that the Group is holding with target principals." The ability to scale with the SaaS model is attractive. A global platform to promote new capabilities and services from & the market is so fragmented there should be rich pickings to put on the platform. I have no idea if this will fall back the placing price or below but the statement "The Placing was significantly oversubscribed" makes me think not. The disappointed could buy in the market not much over the placement price. Read Full Thread Follow Reply
Posted at 19/2/2020 13:08 by mw8156 large volume, by standards today and yesterday with rising share price, ought to be a bullish signal but have no idea what's going on in the background. Read Full Thread Follow Reply

Instem share price data is direct from the London Stock Exchange

Your Recent History

LSE

INS

Instem

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea

V: D: 20230601 02:40:03